Linkage to HIV care and antiretroviral therapy by HIV testing service type in central mozambique: A retrospective cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 2, 2014, Pages

  Gerdts, Sarah E ^a   Wagenaar, Bradley H ^a,b   Micek, Mark A ^a,b,d   Farquhar, Carey ^a   Kariaganis, Marina ^c   Amos, Juvenal ^c   Gimbel, Sarah ^a   Pfeiffer, James ^a,b   Gloyd, Stephen ^a,b   Sherr, Kenneth ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HEALTH ALLIANCE INTERNATIONAL   (United States)

^c MINISTRY OF HEALTH   (Mozambique)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

antiretroviral therapy; HIV testing; HIV testing to care; linkages; Mozambique; operations research

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DELIVERY OF HEALTH CARE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOST TO FOLLOW-UP; MALE; MASS SCREENING; MOZAMBIQUE; ODDS RATIO; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84901486803     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000081     Document Type: Article

References (30)

1. UN Joint Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic. 2013. Available at: http://www.unaids.org/en/media/unaids/ contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en. pdf. Accessed October 25, 2013.
2. Instituto Nacional de Saude. National survey on prevalence, behavioral risks, and information about HIV and AIDS in Mozambique (2009 INSIDA): HIV prevalence. Mozambique Ministry of Health. 2009. Available at: http://www.measuredhs.com/pubs/pdf/HF33/HF33.pdf. Accessed October 25, 2013.
3. Republic of Mozambique: National AIDS Council. Global AIDS Response Progress Report: For the Period 2010-2011, Mozambique. Maputo, Mozambique. 2012. Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/ countryprogressreports/2012countries/ce-MZ-Narrative-Report%5B1%5D.pdf. Accessed October 25, 2013.
4. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8: e1001056.
5. Micek MA, Gimbel-Sherr K, Baptista AJ, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;52:397-405.
6. Larson BA, Brennan A, McNamara L, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010;15(suppl 1):43-47.
7. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-567. (Pubitemid 351931216)
8. Bassett IV, Wang B, Chetty S, et al. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009;51:135-139.
9. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665. (Pubitemid 46763738)
10. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(suppl 1):1-15.
11. Wang B, Losina E, Stark R, et al. Loss to follow-up in a community clinic in South Africa-roles of gender, pregnancy and CD4 count. S Afr Med J. 2011;101:253-257.
12. Losina E, Bassett IV, Giddy J, et al. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010;5:e9538.
13. Kranzer K, Zeinecker J, Ginsberg P, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One. 2010;5: e13801.
14. Bwirire LD, Fitzgerald M, Zachariah R, et al. Reasons for loss to followup among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Trans R Soc Trop Med Hyg. 2008;102: 1195-1200.
15. Lambdin BH, Micek MA, Koepsell TD, et al. Patient volume, human resource levels, and attrition from HIV treatment programs in central Mozambique. J Acquir Immune Defic Syndr. 2011;57:e33-e39.
16. Pfeiffer J, Montoya P, Baptista AJ, et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique-a case study. J Int AIDS Soc. 2010;13:3.
17. Gimbel S, Micek M, Lambdin B, et al. An assessment of routine primary care health information system data quality in Sofala Province, Mozambique. Popul Health Metr. 2011;9:12.
18. Lambdin BH, Micek MA, Koepsell TD, et al. An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique. BMC Health Serv Res. 2012;12:30.
19. Hatcher AM, Turan JM, Leslie HH, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2011;16:1295-1307.
20. Moon TD, Burlison JR, Blevins M, et al. Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president's emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS. 2011;22:621-627.
21. Boyles TH, Wilkinson LS, Leisegang R, et al. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011;6:e19201.
22. Amuron B, Namara G, Birungi J, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290.
23. Maqutu D, Zewotir T, North D, et al. Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study. AIDS Behav. 2011;15:1465-1474.
24. Bassett IV, Regan S, Chetty S, et al. Who starts antiretroviral therapy in Durban, South Africa?⋯ not everyone who should. AIDS. 2010;24 (suppl 1):S37-S44.
25. Brinkhof MW, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6:e1000066.
26. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4:e5790.
27. Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897-1908.
28. Pearson CR, Micek MA, Pfeiffer J, et al. One year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS Behav. 2009;13:1189-1196.
29. Agadjanian V, Hayford SR. PMTCT, HAART, and childbearing in Mozambique: an institutional perspective. AIDS Behav. 2009;13 (suppl 1):103-112.
30. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286:2568-2577. (Pubitemid 33096808)